2026 Laura H. Tang: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	91	11688	10994	5994	5547	336	33110

Overview

Laura H. Tang is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the field of Medicine, with a focused emphasis on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology, and Epidemiology.

The main research topics covered by Tang include:

Gastric Cancer Management and Outcomes
Esophageal Cancer Research and Treatment
Cancer Immunotherapy and Biomarkers
Pancreatic and Hepatic Oncology Research
Genetic factors in colorectal cancer
Gastrointestinal Tumor Research and Treatment
Metastasis and carcinoma case studies

Recent significant publications authored or co-authored by Laura H. Tang include:

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer (2023), published in Nature
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline (2020), published in Journal of Clinical Oncology
Validation of a digital pathology system including remote review during the COVID-19 pandemic (2020), published in Modern Pathology
Reprogrammed Schwann Cells Organize into Dynamic Tracks that Promote Pancreatic Cancer Invasion (2022), published in Cancer Discovery
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations (2020), published in Neuroendocrinology

Tang frequently publishes in venues such as the Journal of Clinical Oncology, Annals of Surgery, Annals of Surgical Oncology, bioRxiv (Cold Spring Harbor Laboratory), and Modern Pathology.

Frequent collaborators include researchers with multiple joint publications:

Yelena Y. Janjigian (48 collaborations)
Vivian E. Strong (45 collaborations)
Steven B. Maron (34 collaborations)
Geoffrey Y. Ku (31 collaborations)
Daniel G. Coit (26 collaborations)

Best Publications

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds

6006
Citations
Daxx/atrx, men1, and mtor pathway genes are frequently altered in pancreatic neuroendocrine tumors

Yuchen Jiao;Chanjuan Shi;Barish H. Edil;Roeland F. De Wilde

1824
Citations
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors

Shinichi Yachida;Efsevia Vakiani;Catherine M. White;Yi Zhong

551
Citations
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.

Olca Basturk;Zhaohai Yang;Laura H. Tang;Ralph H. Hruban

530
Citations
Clinically Aggressive Solid Pseudopapillary Tumors of the Pancreas: A Report of Two Cases With Components of Undifferentiated Carcinoma and a Comparative Clinicopathologic Analysis of 34 Conventional Cases

Laura H Tang;Hakan Aydin;Murray F Brennan;David S Klimstra

466
Citations
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set

David S. Klimstra;Irvin R. Modlin;N. Volkan Adsay;Runjan Chetty

439
Citations
Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.

Zhaohai Yang;Laura H. Tang;David S. Klimstra

398
Citations
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.

Laura H. Tang;Olca Basturk;Jillian J. Sue;David S. Klimstra

394
Citations
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis

Y.Y. Janjigian;D. Werner;C. Pauligk;K. Steinmetz

387
Citations
Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades

Jordan M. Winter;Murray F. Brennan;Laura H. Tang;Michael I. D’Angelica

381
Citations
Small-Cell Carcinomas of the Gastrointestinal Tract: A Review

Baruch Brenner;Laura H. Tang;David S. Klimstra;David P. Kelsen

369
Citations
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Angela N. Bartley;Mary Kay Washington;Carol Colasacco;Christina B. Ventura

360
Citations
Negative regulation of tumor suppressor p53 by microRNA miR-504.

Wenwei Hu;Chang S. Chan;Rui Wu;Cen Zhang

359
Citations
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.

Laura H Tang;Jinru Shia;Robert A Soslow;Deepti Dhall

355
Citations
Molecular Classification of Gastric Cancer: A New Paradigm

Manish A Shah;Raya Khanin;Laura H Tang;Yelena Y. Janjigian

353
Citations
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.

Jonathan R. Strosberg;Thorvardur R. Halfdanarson;Andrew M. Bellizzi;Jennifer A. Chan

343
Citations
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.

Yelena Y. Janjigian;Francisco Sanchez-Vega;Philip Jonsson;Walid K. Chatila

340
Citations
Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.

Laura H. Tang;Mithat Gonen;Cyrus Hedvat;Irvin M. Modlin

339
Citations
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas

Laura H. Tang;Brian R. Untch;Diane L Reidy;Eileen Eileen O'Reilly

337
Citations
Pancreatic Adenocarcinoma: The Actual 5-Year Survivors

Cristina R. Ferrone;Murray F. Brennan;Mithat Gonen;Daniel G. Coit

336
Citations

Frequent Co-Authors

David S. Klimstra Yale University

Murray F. Brennan Memorial Sloan Kettering Cancer Center

David P. Kelsen Memorial Sloan Kettering Cancer Center

Daniel G. Coit Memorial Sloan Kettering Cancer Center

Peter J. Allen Duke University

Manish A. Shah Cornell University

Mithat Gonen Memorial Sloan Kettering Cancer Center

Irvin M. Modlin Yale University

William R. Jarnagin Memorial Sloan Kettering Cancer Center

Jinru Shia Memorial Sloan Kettering Cancer Center

External Links

Personal website of Laura H. Tang

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in medicine but considering alternative or complementary paths, a variety of online degrees can expand your career opportunities. Many registered nurses opt for rn to fnp programs, which offer a flexible bridge to become a Family Nurse Practitioner. These programs are ideal for RNs seeking advanced clinical roles and greater autonomy in patient care.

Nutrition is another flourishing health sector. Pursuing an online dietitian degree allows students to specialize in healthy eating, patient counseling, and disease prevention, leading to opportunities in hospitals, public health, or private practice.

If your interests lean toward healthcare management rather than direct patient care, accredited leadership programs are also available. cahme accredited online mha programs provide rigorous training in administration, policy, and leadership, preparing graduates to oversee medical facilities and teams.

For nurses seeking advancement but facing clinical placement challenges, flexible rn to bsn programs without clinicals can be a practical solution—enabling degree completion at your own pace and on your own schedule.